360 likes | 725 Views
Hemoglobinopathy. John Matthews and Dilys Rapson. Hemoglobin structure. α. β. β. α. heme. Hemoglobins in normal adults. α. β. α. γ. α. δ. β. α. γ. α. δ. α. HbA. HbF. HbA 2. 98%. ~1%. <3.5%. Hemoglobin structure. α. β. β. α. heme. Heme. Globin.
E N D
Hemoglobinopathy John Matthews and Dilys Rapson
Hemoglobin structure α β β α heme
Hemoglobins in normal adults α β α γ α δ β α γ α δ α HbA HbF HbA2 98% ~1% <3.5%
Hemoglobin structure α β β α heme
The Oxygen Dissociation Curve pAO2 pVO2 normal e.g. α2β2 abnormal e.g. β4
Hemoglobin synthesis 25% 25% 0.5% 1.5% 48% α α γ δ β α α γ δ β 25% 25% 0.5% 1.5% 48% Chromosome 16 Chromosome 11
Hemoglobinopathydefinition An inherited mutation of the globin genes leading to a qualitative or quantitative abnormality of globin synthesis
Structural hemoglobinopathy Amino acid substitution in the globin chain e.g. sickle hemoglobin (HbS)
The Thalassemias • Syndromes in which the rate of synthesis of a globin chain is reduced • beta thalassemia - reduced beta chain synthesis • alphathalassemia – reduced alpha chain synthesis
Sickle Cell Anemia (HbSS) • β6 glu to val • ‘tactoids’ at low oxygen tension • sickled red cells • small blood vessel occlusion • tissue infarction
Sickle Cell Anemia – blood film SickleCells Erythroblasts Howell-Jolly Body
Sickle cell anemia – clinical features • Hemolysis • Occlusion of blood vessels by sickled red cells
Sickle Cell Anemia - treatment • Opiates and hydration for painful crises • Pneumococcal vaccination • Retinal surveillance • Hydroxyurea • Transfusion for serious manifestations • Stem cell transplant • Support, folate, iron chelation
Sickle Cell Trait • Heterozygous state for HbS (HbAS) • No serious clinical consequences • Sudden death during intensive training • Hematuria, isosthenuria (renal papillary necrosis)
Beta thalassemia • Impaired production of beta chain • beta thalassemia minor – heterozygous (or trait) • beta thalassemia major - homozygous
Beta thalassemia trait • No symptoms • Mild microcytic anemia
Beta thalassemia major • No beta chain produced (no HbA) • Severe microcytic anemia occurs gradually in the first year of life • Marrow expansion • Iron overload • Growth failure and death
Beta thalassemia major Male 18 years
Beta thalassemia major treatment • Transfusion • Iron chelation • Stem cell transplant
Hemoglobinopathy-antenatal diagnosis • Test partners of heterozygous or affected individuals • Antenatal diagnosis from DNA obtained by chorionic villus sampling, or by amniocentesis